Literature DB >> 27758701

Targeting Obesity for the Prevention of Chronic Cardiovascular Disease Through Gut Microbiota-Herb Interactions: An Opportunity for Traditional Herbs.

Feng Chen1, Jun Jiang2, Dan-Dan Tian3, Qi Wen1, Yong-Hui Li1, Jun-Qing Zhang1, Chen Cheng4, Tengfei Wang5.   

Abstract

Cardiovascular disease still remains the primary cause of death worldwide and obesity is becoming recognized as one of the most critical contributing risk factors. The increased prevalence of obesity casts a cloud over the global health and the whole societies and will still be burdened in the future. Therefore, prevention and therapy of obesity is a beneficial strategy for the prevention of chronic cardiovascular disease. Numerous studies have demonstrated that gut microbiota takes part in human health and disease including obesity. Traditional herbs hold great potential to improve people's health and wellness, particularly in the area of chronic inflammatory diseases although the mechanisms of action remain poorly understood. Emerging explorations of gut microbiotaherb interactions provide a potential to revolutionize the way we view herbal therapeutics. This review summarizes the experimental studies performed on animals and humans regarding the gut microbiota-herb interactions targeting obesity. This review also discusses the opportunity of herbs with potent activities but low oral bioavailability conundrum for prevention and therapy for obesity and related cardiovascular disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Obesity; cardiovascular disease; gut microbiota; gut microbiota-herb interactions; microbiotazzm321990availability; oral availability conundrum

Mesh:

Substances:

Year:  2017        PMID: 27758701     DOI: 10.2174/1381612822666161014115724

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Effect of Sheng-Jiang Powder on Obesity-Induced Multiple Organ Injuries in Rats.

Authors:  Juan Li; Yu-Mei Zhang; Jun-Yi Li; Lv Zhu; Hong-Xin Kang; Hong-Yu Ren; Huan Chen; Ling Yuan; Yi-Fan Miao; Mei-Hua Wan; Wen-Fu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-29       Impact factor: 2.629

Review 2.  Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer.

Authors:  Hua-Zhong Ying; Wei Xie; Meng-Chuan Wang; Jia-Qi He; Huan-Huan Zhang; Chen-Huan Yu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-16       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.